Funded Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Gross, Howard M

Dayton Clinical Oncology Program
United States

Dayton Clinical Oncology Program 5UG1CA189957-11 Vanessa A. White, M.P.H.
Grueber, Wesley B

Columbia University Health Sciences
United States

Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy 5R21CA274588-02 Rachel Altshuler, Ph.D.
Guan, Yue

Emory University
United States

Testing a Low Cost Population- and Theory-Based Outreach Intervention to Engage Ovarian Cancer Survivors and their Close Relatives to Consider Genetic Services 5U01CA240581-04 Marjorie Perloff, M.D.
Gudas, Lorraine J

Weill Medical Coll Of Cornell Univ
United States

CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention 5R01CA270248-02 Winfred Malone, Ph.D., M.P.H.
Gunter, Marc James

Imperial College Of Science, Technology And Medicine
United States

PROMINENT: Discovering the molecular signatures of cancer PROMotion to INform prevENTion 1OT2CA290880-01
Haab, Brian B.

Van Andel Research Institute
United States

Subpopulations of Pancreatic Cancer Cells Defined by Glycan Markers 5U01CA226158-05 Matthew Young, Ph.D.
Hall, Daniel Lee

Massachusetts General Hospital
United States

Innovating CBT-I for Cancer Survivors: An Optimization Trial 1R21CA279248-01A1 Ellen Richmond, M.S., GNP-BC
Halmos, Balazs

Montefiore Medical Center (Bronx, Ny)
United States

MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM 5UG1CA189859-11 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Hanash, Samir M

University Of Tx Md Anderson Can Ctr
United States

Clinical Validation Center for Lung Cancer Early Detection 5U01CA271888-03 Guillermo Marquez, Ph.D.
Hanks, Brent Allen

Duke University
United States

Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities 5R01CA251136-04 Marjorie Perloff, M.D.